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The inherent cellular capacity to repair radiation-induced DNA
damage is one of the most important determinants of radioresis-
tance. Although DNA double-strand break (DSB) repair pathways
are unquestionably important in determining the lethality of
radiation-induced DNA damage (Giaccia et al, 1985; Taccioli et
al, 1994; Kirchgessner et al, 1995; Lees-Miller et al, 1995), DSB
rejoining capacity does not correlate well with the relative radio-
resistance of human tumour cell lines (reviewed in Olive et al,
1994). This disparity between DSB rejoining capacity and cellular
radiosensitivity in human tumour cells may be partly attributable
to the inability of the currently available techniques to dissociate
complex DSBs (that are likely to have the most profound bio-
logical consequences) from less innocuous DSBs. An alternative
explanation for this disparity is that the majority of the techniques
used to measure DSB induction and rejoining give no information
on the fidelity of DSB rejoining. Thus, cells that have a high DSB
rejoining capacity may not necessarily be repairing DSBs effi-
ciently, and could even be generating chromosomal aberrations
during DSB rejoining. Interestingly, in contrast to DSB rejoining
levels, the level of radiation-induced chromosomal aberrations
correlates well with radiosensitivity in both tumour (Lambin et al,
1994; Sasai et al, 1994) and fibroblast (Russell et al, 1995) cells.
We have recently reported that DSB rejoining fidelity signifi-
cantly (P < 0.001) correlates with the clinically relevant radio-
sensitivity, i.e. SF2, of eight human tumour cell lines (Britten et al,
1997). Nuclear protein extracts from radiosensitive, yet overtly
DSB rejoining proficient, tumour cells were found to be less
capable of correctly rejoining EcoRI-induced DSBs than were
similar extracts from radioresistant tumour cells. The fidelity with
which restriction endonuclease-induced DSBs are repaired within
the intact cellular environment also varies with respect to SF2
values in human tumour cell lines, with the most radioresistant cell
lines exhibiting a higher fidelity of DSB repair than their radio-
sensitive counterparts (Powell and McMillan, 1991; Powell et al,
1992, 1994). It has been suggested that restriction endonuclease-
generated DSBs act as substrates for proteins that are involved in
the (abnormal) conversion of DSBs into chromosomal aberrations
(Bryant and Liu, 1994). This conclusion is supported by the fact
that ataxia telangiectasia (AT) and irs cells exhibit high DSB
misrejoining activity (Cox et al, 1984; Thacker and Ganesh, 1990;
Ganesh et al, 1993; Powell et al, 1993; Lou et al, 1996), and
generate high levels of chromatid-type aberrations in response to
restriction endonuclease-induced DSBs (Liu and Bryant, 1993;
Bryant, and Liu, 1994).
The biochemical basis for the differential level of DSB misre-
joining activity in nuclear protein extracts from radiosensitive and
radioresistant tumour cells is presently unknown, although we have
shown that the high DSB misrejoining activity in radiosensitive
tumour cells was not a consequence of non-specific endonuclease
activity but rather due to an increase in non-conservative DSB
rejoining activity that results in losses of between 40 and 440 bp
of DNA (Britten et al, 1997). Furthermore, previous studies have
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Summary The induction of collateral radioresistance after the development of cisplatin resistance is a well-documented phenomenon;
however, the exact processes that are responsible for the cisplatin-induced radioresistance remain to be elucidated. There was no obvious
difference in the level of radiation-induced DNA double strand breaks (DSBs), in DSB rejoining rates, or the level of the catalytic subunit of the
DNA-dependent protein kinase (DNA-PKcs) in the cisplatin- and radiation-sensitive 2780/WT and cisplatin-resistant 2780/CP cell lines.
However, there was a significantly (P < 0.01) lower level of DSB misrejoining activity within nuclear protein extracts derived from the cisplatin-
and radiation-sensitive 2780/WT and OAW42/WT tumour cell lines than in similar extracts from their cisplatin- (and radiation-) resistant
2780/CP and OAW42/CP counterparts. All of the DSB misrejoining events involved deletions of between 134 and 444 bp that arose through
illegitimate recombination at short repetitive sequences, such as those that arise through non-homologous repair (NHR). These data further
support the notion that the radiosensitivity of DSB repair proficient human tumour cell lines may be partly determined by the predisposition of
these cell lines to activate non-conservative DSB rejoining pathways. Furthermore, our data suggest that the induction of acquired cisplatin
resistance is associated with a two- to threefold decrease in the activity of a non-conservative DSB rejoining mechanism that appears to be a
manifestation of NHR.
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AT cellular protein extracts were primarily deletions arising from
illegitimate recombination, i.e. the DNA recombines at short
sequence repeats that are frequently far apart (Thacker et al, 1992).
These data raise the possibility that the radiosensitivity of DSB
rejoining-proficient human tumour cell lines may be partly deter-
mined by their predisposition to activate non-conservative DSB
rejoining pathways. Conversely, a radioresistant phenotype might
arise through the suppression (either inherent or environmentally
induced) of such rejoining pathways. The testing of such a hypoth-
esis requires a model system consisting of genetically matched cell
lines and the ability to stably induce a radioresistant phenotype.
We, and others, have reported that the induction of cisplatin resis-
tance frequently (but not invariably) leads to the induction of
collateral radioresistance in human tumour cell lines (Louie et al,
1985; Hida et al, 1989; Twentyman et al, 1991; Britten et al, 1993,
1994). Interestingly, the induction of collateral radioresistance
only occurs in those cisplatin-resistant cells that were derived from
inherently radiosensitive parental cells (Britten et al, 1994).
Furthermore, the level of cisplatin-induced radioresistance was
independent of the level of cisplatin resistance induced, but highly
dependent upon the inherent radiosensitivity of the parental cell
lines with the most radiosensitive cells showing the greatest
degree of cisplatin-induced collateral radioresistance (Britten et al,
1994). The possibility, therefore, exists that the induction of a
radioresistant phenotype after the development of cisplatin resis-
tance in radiosensitive tumour cell lines is a consequence of
cisplatin-induced changes in the DNA damage-response path-
ways, which manifest themselves through alterations in the
fidelity of DSB rejoining. We, thus, determined whether the induc-
tion of collateral radioresistance in the human 2780 and OAW42
ovarian cancer cell lines was associated with an alteration in the
level and/or fidelity of DSB rejoining.
MATERIALS AND METHODS
Cell lines
The 2780/WT and OAW42/WT cell lines are single-cell derived cell
lines that we established from the human A2780 and OAW42
ovarian tumour cell lines respectively. The cisplatin-resistant variants
2780/CP and OAW42/CP were developed from the 2780/WT and
OAW42/WT cell lines, respectively, by stepwise incubation with
cisplatin. Relative to their respective parental cell lines, the 2780/CP
and OAW42/CP cell lines are three- and 3.7-fold more resistant to
clinically relevant (i.e. 1 mg ml–1) cisplatin concentrations (Table 1).
Both the parental and cisplatin-resistant variants were routinely
maintained as log-phase monolayer culture in Dulbecco’s modified
Eagle medium (DMEM)/F12 medium (Life Technologies, Grand
Island, NY, USA) supplemented with 10% fetal calf serum (FCS:
Life Technologies) and 1% penicillin–streptomycin at 37°C in a
humidified 5% carbon dioxide/95% air atmosphere.
Chinese hamster ovary (CHO) cells were used as a reference cell
line to facilitate interlaboratory comparisons. The level of DSB
misrejoining activity in CHO (strain AA8) cells has been previ-
ously characterized (Britten et al, 1997), and we have also estab-
lished their susceptibility to DSB induction after exposure to 60Co
g-rays (Murray et al, 1994). The CHO-AA8 cells were maintained
in monolayer culture in McCoy’s 5A medium (Hsu’s modification;
Life Technologies) supplemented with 10% FCS and antibiotics
and passaged every 2–3 days to ensure exponential growth.
Radiation clonogenic cell survival assays
The radiosensitivity of the cell lines used in this study have been
previously established (Britten et al, 1993, 1994). However, to
ensure that the radiosensitivity of the cells recovered from frozen
storage had not altered and to facilitate a better statistical compar-
ison between radiosensitivity and DNA repair fidelity, complete
radiation survival curves (over the range 0–10 Gy) were
constructed on the same batch of cell lines used to prepare the
nuclear protein extracts. To ensure that the radiation sensitivity
determined on this occasion was not erroneous, radiation sensi-
tivity was determined a further two times in the subsequent 7 days.
The radiosensitivity parameters presented in Table 1 represent the
pooled data from all three survival curve experiments. In no
instance did we find that the radiation sensitivity determined on
the day that the protein extract was prepared varied from either
historical data, or from that observed in the subsequent assays. The
procedure followed for these experiments is outlined below. On
the day of the experiment, the cell monolayers were washed with
sterile prewarmed (37°C) PBS, and detached using 0.25%
trypsin/1 mM EDTA at 37°C. The cell pellets were then washed
twice with warm PBS. Two-thirds of the cell pellet was used to
prepare the nuclear protein extract (see below) whereas the other
third was used to determine radiosensitivity: the cells were resus-
pended in DMEM/F12 media (supplemented with 10% FCS and
antibiotics), and seeded at densities of between 102 and 5 ´ 104
cells per 60 mm tissue culture dish. Triplicate plates were set up
for each of the five radiation dose levels, placed in aluminium irra-
diation chambers and irradiated using a 60Co irradiator at a dose
rate of 6 Gy min–1. After 15 days at 37°C (5% carbon dioxide/95%
air), the colonies were fixed in 70% ethanol and stained with 10%
methylene blue, and those colonies containing greater than 50 cells
were counted.
Data handling and presentation
The experimental data were fitted to the linear-quadratic equation:
–Ln S = aD + bD2
In which S is equivalent to the surviving fraction at a given dose, D,
and a and b are constants. The data were fitted to a linear-quadratic
function using the non-linear regression program of the Prizm soft-
ware package (Graphpad Software, San Diego, CA, USA).
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Table 1 Characterization of the radiation and cisplatin sensitivity of the
human ovarian tumour cell lines and CHO-AA8 cells
g-Rays Cisplatin
Cell line a (Gy–1) b (Gy–2)S F 2 D0.1 (Gy) SF1
a
2780/WT 0.363 (0.043)b 0.056 (0.006) 0.38 3.95 0.29
2780/CP 0.343 (0.038) 0.011 (0.009) 0.48 5.68 0.88
OAW42/WT 0.549 (0.042) 0.015 (0.005) 0.31 3.79 0.22
OAW42/CP 0.261 (0.006) 0.025 (0.006) 0.53 5.73 0.81
CHO-AA8 0.154 (0.022) 0.032 (0.002) 0.64 6.41 0.91
aFraction of cells surviving exposure to 1 mg ml–1 cisplatin. bStandard error of
mean.Measurement of g-ray-induced DNA double-strand
breaks
A slightly modified version of our previously published pulsed
field gel electrophoresis (PFGE) technique (Murray et al, 1994)
was used to determine the level of g-ray-induced DSBs. The initial
level of DSBs induced over the dose range 0–10 Gy was deter-
mined by immediately embedding the irradiated tumour cells in
InCert agarose (FMC, Rockland, ME, USA; 1% solution in PBS),
and then incubating the agarose plugs in 5 ml of ESP (500 mM
EDTA, 1% w/v sarkosyl, 1 mg ml–1 proteinase K; pH 9) for 24 h at
47°C. The DSB repair capacity of the cell lines was determined by
measuring the disappearance of DSB over a 240-min time period.
Agarose plugs were prepared as described above using tumour
cells that had either just been irradiated with 30 Gy or that had
been left at 37°C for 10, 30 or 240 min. After three washes (for 1 h
each) in sterile 0.5 ´ TBE buffer (45 mM Tris base, 45 mM boric
acid, 1 mM EDTA; pH 7.2), the DNA in the plugs (~5 mg from
~9 ´ 104 cells) was separated using a CHEF-DR II system (Bio-
Rad, Mississauga, Ontario, Canada). The DNA was separated for
18 h by a 40-V (~1.21 V cm–1) electric field, with a switch time of
75 min and a field angle of 120°. The buffer (0.5 ´ TBE) was recir-
culated through a temperature-regulating unit maintained at 25°C.
After electrophoretic separation, the DNA was transferred to
Hybond-N+ nylon membranes (Amersham, Arlington Heights, IL,
USA) by capillary blotting, and baked at 80°C for 2 h. After prehy-
bridization of the membranes for 4 h at 45°C in Hybrisol I (Oncor,
Gaithersburg, MD, USA), the membrane was hybridized with 32P-
labelled human Alu+ probe for 18 h at 42°C. Unbound probe was
removed by washing membranes three times in 2 ´ SSC/0.1% SDS
at room temperature and twice in 0.2 ´ SSC/0.1% SDS at 20°C.
The distribution of radioactivity between the plug and lane was
then determined using a GS-250 Molecular Imager (Bio-Rad).
DNA repair fidelity assay
The fidelity of DSB repair effected by nuclear protein extracts
from the cell lines was assessed using a slightly modified version
of our cell-free plasmid reactivation assay (Britten et al, 1997).
Briefly, this plasmid reactivation assay determines the ability of
nuclear protein extracts to correctly rejoin a simple staggered
(EcoRI-induced) DSB within the lacZa complementation gene of
the pUC18 plasmid. DNA repair fidelity is scored by the loss of
lacZa gene function (a-complementation of b-galactosidase):
misrejoining of the DSBs will result in a mutated lacZa sequence
that will produce colourless colonies when transfected into
Escherichia coli, whereas the correct rejoining will lead to the
production of blue colonies. An uncut ampicillin-resistance gene
(amp1) acts as a selectable marker for transfection efficiency, and
an internal control for non-specific nuclease activity.
Nuclear protein extracts were prepared from the cell lines as
previously described (Britten et al, 1997). The experimental condi-
tions used to derive the data presented in this paper are described
below. Two micrograms of linearized plasmid DNA and 1 mg of
nuclear protein extract were mixed in 50 ml containing 50 mM tris-
HCl (pH 7.6), 10 mM magnesium chloride, 1 mM ATP, 1 mM DTT,
50 mM dNTPs and 5% (w/v) polyethylene glycol-8000, and incu-
bated at 18°C for 24 h. The plasmid DNA was then isolated by
spinning down the reaction mixture through Ultrafree-Probind
Filter column (Millipore Corporation, Bedford, MA, USA). For
quality control purposes, an aliquot was removed and treated with
T4-ligase (Life Technologies) before being further processed.
The recovered plasmid was diluted fivefold with TE buffer
(pH 7.6) and then transfected into the E. coli DH5a strain using
the Gibco-BRL protocol for DH5a bacteria. The transformed cells
were then plated out on premade LB plates [LB medium/0.7% agar
containing 100 mg ml–1 ampicillin, 20 mg ml–1 X-gal (5-bromo-4-
chloro-3-indolyl-b-D-galactopyranoside) and 200 mg ml–1 of IPTG
(an inducer of lacZa gene function)]. An aliquot of cells was also
plated out on LB plates that contained no ampicillin to determine
bacterial cell viability/plating efficiency. After overnight incuba-
tion at 37°C, and a subsequent 4-h incubation at 4°C the number of
blue and white colonies (that were greater than 1 mm in diameter)
was determined. To ensure that our results were not attributable
to experimental artefacts, it was necessary to undertake several
quality control experiments. To guard against the possibility of
misidentifying ‘white’ colonies, it was necessary to restreak the
‘mutant’ colonies onto fresh selection medium to verify the muta-
tion in the lacZa gene. It was also necessary to determine bacterial
cell viability (in the absence of ampicillin) to establish whether
nuclease activity was affecting the integrity of the ampr-gene, and
to correct for variations in bacterial cell plating numbers.
Moreover, to correct for the presence of small amounts of undi-
gested plasmid, ligation activity within the bacteria (although as
linearized plasmid molecules do not transform bacteria very well
this was not a major concern) and importantly any DNA modifica-
tion by the bacteria, we performed transformation experiments
using EcoRI-digested plasmid that had not been exposed to
nuclear protein extracts. Before analysis, the number of ‘sponta-
neously’ arising colonies were subtracted from the number of
colonies arising from the extract-treated plasmid.
Comparative studies on the fidelity of DSB rejoining effected
by nuclear protein extracts from the radiosensitive and radioresis-
tant cell lines were performed simultaneously using the same batch
of competent cells, reagents and EcoRI-digested plasmid DNA. A
minimum of three experiments were performed with each nuclear
protein extract, the results presented in this paper represent the
pooled data from these experiments.
DNA sequencing
Plasmid DNA was isolated from six randomly selected white and
five blue clones generated after exposure to the nuclear protein
extract of the 2780/WT cell line. The region of the pUC18 plasmid
corresponding to nt. 150–777 [which we have previously shown to
encompass the majority of deletional events (Britten et al, 1997)]
was then polymerase chain reaction (PCR) amplified using a
GeneAmp PCR system 9600 (Perkin Elmer) and the following
set of primers: forward, 5¢-CGGCA TCAGA GCAGA TTGTA-3¢
(primer 2F); reverse, 5¢-TGGAT AACCG TATTA CCGCC-3¢
(primer 2R); and the following PCR conditions: 95°C, 2 min; 40
cycles of 95°C, 15 s, 60°C, 30 s, 72°C, 15 s; 72°C, 7 min. We subse-
quently sequenced the DNA from the white clones to ascertain the
nature of the mutations in the lacZa gene. Primers 2 F and 2R were
used to sequence the transcribing and non-transcribing strand,
respectively, using the Prism ABI Dye terminator sequencing kit
(Perkin Elmer) in accordance with the manufacturer’s instructions
with the following PCR conditions: 25 cycles of 96°C, 10 s, 50°C,
5 s, 60°C, 4 min in a GeneAmp PCR system 9600.
Western blotting
A recent report suggests that cisplatin–DNA adducts (especially
DNA interstrand cross-links) inhibit the activity of DNA-PK
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radioresistance after the development of cisplatin resistance may
arise through the constitutive up-regulation of DNA-PK activity.
We, thus, determined the level of the catalytic subunit of the DNA-
dependent protein kinase (DNA-PKcs) in nuclear protein extracts
from 2780/WT and 2780/CP cells. The protein content of the
2780/WT and 2780/CP nuclear protein extracts was adjusted to
3 mg ml–1 and then denatured by boiling the protein in the presence
of 1.5% sodium dodecyl sulphate (SDS) for 5 min, 40 mg of each
nuclear protein extract was then electrophoretically (200 V) sepa-
rated on a 7% polyacrylamide gel maintained at 20°C. The sepa-
rated protein bands were transferred to nitrocellulose membranes
using a Biorad Mini Transblot apparatus (Bio-Rad) for 1.5 h at
75 V (maintained at 20°C). The membranes were then incubated
for 4 h in blocking buffer [PBS, 0.1% v/v Tween-20, 5% (w/v)
skim-milk powder], and then incubated in the presence of a
(1:3000) rabbit anti-DNA-PKcs antibody (kindly supplied by Dr
Allalunis-Turner) overnight at 4°C with gentle agitation. The blots
were then washed four times (10 min each) in TBST (20 mM Tris,
pH 7.5, 150 mM sodium chloride, 0.05% Tween-20) and incubated
with a 1:2500 dilution of HRP-tagged goat anti-rabbit antibody
(Santa Cruz Biotechnology, Santa Cruz, CA, USA). After 30 min
incubation, the membranes were washed six times (5 min per wash)
in TBST, then incubated with Supersignal Chemiluminescent
Reagent (Pierce, Rockford, IL, USA) for 5 min and exposed to
high-sensitivity chemiluminescence phosphor-imager screens
(Bio-Rad) for 5 min, and the distribution and intensity of the fluo-
rescence determined using a GS-250 Molecular Imager (Bio-Rad).
RESULTS
The initial phase of our study determined whether the enhanced
radioresistance of the 2780/CP cell line was attributable to a
decrease in the level of DSBs induced by radiation and/or to an
enhanced level of DSB rejoining. For these studies, we used a
PFGE technique that did not require preincubation of the cells
with radioisotopes, thereby eliminating any potential induction of
radioresponsive processes or alteration in cell survival. The minor
alterations in the cell cycle distributions of the two 2780 cell lines
studied had no obvious impact on the level of DNA migration
from the embedded nuclei. For unirradiated 2780/WT cells,
96.9  ± 0.7% (n = 18) of the DNA was retained in the plug after
electrophoresis, whereas for unirradiated 2780/CP cells 97.8 ±
0.9% (n = 16) of the DNA was retained in the plug after elec-
trophoresis. The low dose (i.e. < 10 Gy) resolution of the PFGE
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Figure 1 PFGE-induced elution of DNA (% DNA migrating) from plugs
containing embedded nuclei of 2780/WT (l l) and 2780/CP (l) cells that had
been exposed to graded doses of 60Co g-radiation. DNA elution at each dose
point was assayed by at least three separate experiments, each experiment
consisting of at least four replicate dishes
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Figure 2 The rejoining of radiation (30 Gy of 60Co g-rays)-induced DNA
DSB with respect to time elapsed from irradiation in 2780/WT (open bar) and
2780/CP (solid bar) cells
Table 2 Ampicillin-resistant bacterial clones generated after transfection of DH5a bacteria with EcoRI-digested pUC18 molecules after
exposure to T4 ligase, or various nuclear protein extracts. (Values represent the mean values ± s.e.m. of data that have been corrected for
‘background’ plasmid rejoining by subtraction of internal control data)
Treatment Total colonies White colonies Total colonies Misrepair
produceda produceda producedb frequency
EcoRI only 43.44 ± 13.22 0.055 ± 0.055 46.82 ± 21.07 0
EcoRI®T4 ligase 4950 ± 45.92 0.33 ± 0.31 5125 ± 67.23 0
EcoRI ® Nuclear protein ® T4 ligase 5744 ± 67.12 0.19 ± 0.08 5463 ± 79.19 0
2780/WT 93.6 ± 15.09 14.3 ± 3.66 96.04 ± 15.50 15.06 ± 2.40
2780/CP 126.7 ± 13.56 8.8 ± 1.39 121.80 ± 23.62 4.94 ± 0.95
OAW42/WT 113.7 ± 4.08 8.0 ± 0.53 116.00 ± 4.16 7.04 ± 0.35
OAW42/CP 141.4 ± 7.91 5.3 ± 0.74 133.40 ± 7.46 3.85 ± 0.54
CHO-AA8 126.6 ± 21.60 4.3 ± 1.85 164.2 ± 27.77 3.18 ± 0.85
aNumber of ampicillin-resistant bacterial colonies produced per 104 bacterial cells plated. bNumber of ampicillin-resistant bacterial colonies
produced normalized to bacterial cell viability.protocol facilitated by phosphorimager analysis has allowed us to
measure radiation-induced DSBs by PFGE after biologically rele-
vant (i.e. survival curve) doses of radiation. The induction of DSBs
was essentially linear with respect to dose in both the 2780/WT
and 2780/CP cell lines (Figure 1). The level of DSB induction in
the CHO-AA8 cell line was essentially identical to that observed
when prelabelled CHO cells were used, suggesting that the sensi-
tivity of the Alu+ based Southern blotting technique was compa-
rable to our earlier PFGE protocol (Murray et al, 1994).
Having established that the induction of collateral radioresistance
in the 2780/CP cell lines was not attributable to a reduction in the
level of DSB induction (a possibility given that the 2780/CP line has
a higher level of glutathione (GSH) than the parental 2780/WT cell
line), we determined whether there were any differences in the
capacity of these two cell lines to rejoin radiation-induced DSBs. As
repair time increased, less DNA migration into the gel was observed
in both cell lines; however, there were no significant differences in
the level of residual DSBs present in the 2780/WT and 2780/CP cell
lines over the 240-min time course (Figure 2). Finally, the reduction
in radiosensitivity after the development of cisplatin resistance in the
2780/CP cell was not associated with any significant change in
DNA-PKcs protein levels from those observed in the 2780/WT cell
line (data not shown).
The level and fidelity of DSB rejoining effected by nuclear
protein extracts from the 2780/WT and 2780/CP cell lines was
then determined using our cell-free plasmid reactivation assay.
There was no significant difference in the number of bacterial
colonies produced after transformation of the DH5a cells with
EcoRI-linearized pUC18 plasmid that had been exposed to nuclear
protein extracts from the 2780/WT and 2780/CP cells (Table 2).
However, the induction of cisplatin resistance in the 2780/CP cell
line was associated with a threefold (P < 0.01) reduction in the
frequency with which lacZa-deficient (white) colonies were
formed (Figure 3, Table 2). We established whether this reduction
in DSB misrejoining activity after the induction of cisplatin resis-
tance was a cell-line-specific phenomenon by establishing the
fidelity of DSB rejoining in another human ovarian tumour cell
line (OAW42/WT) and its cisplatin-resistant variant (OAW42/CP).
EcoRI-linearized pUC18 plasmid that had been exposed to nuclear
protein extracts from the OAW42/WT and OAW42/CP cells gave
essentially identical levels of bacterial transformation (Table 2).
Although there was approximately twofold less DSB misrejoining
activity in the OAW42/WT than in the 2780/WT nuclear protein
extracts, the induction of cisplatin resistance in the OAW42 cell
line was also associated with a significant (P < 0.001) reduction in
DSB misrejoining activity (Figure 3).
PCR analysis of six randomly selected white (mutant) colonies
that were generated after exposure of the EcoRI-linearized pUC18
plasmid to 2780/WT nuclear protein revealed the inactivation of the
lacZa gene in all the clones studied was attributable to deletion
events, giving a PCR product of between 184 and 494 bp.
Sequencing of the ‘mutant’ pUC18 plasmids revealed that in five of
the six clones the deletion arose via the illegitimate rejoining
between distant short-sequence DNA repeats (microhomologies).
The inactivation of the lacZa gene in the other clone (W5) was
attributable to a more complex deletion event: in this instance,
nt 290–335 and nt 354–748 were deleted, the intervening 18-bp
fragment (nt 336–353) was retained but had been inverted. The
rejoining of the inverted 18-bp fragment appears to have occurred
via illegitimate rejoining events between DNA microhomologies at
either end of the fragment and the corresponding sequences at the
termini of the pUC18 plasmid. Interestingly, approximately half of
the randomly selected mutant clones had deletion break points
close to nt 450 (the original EcoRI cleavage site) and to nt 700.
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Figure 3 DSB misrejoining activity in the human ovarian tumor cell lines
and in CHO cells. Misrejoining capacity was assayed by at least three
separate experiments
Table 3 Characterization of the inactivating lacZa mutations generated by 2780/WT nuclear protein extracts
Bacterial clone PCR product Nature of mutation Deleted region DNA sequence at
size (bp) (nt) deletion
breakpoints
Blue 628 – – –
W1 494 Deletion (134 bp) 413–548 GCCT
W2 380 Deletion (248 bp) 449–698 CTC
W3 375 Deletion (253 bp) 450–703 CTC
W4 377 Deletion (251 bp) 447–698 GCT
W5 190 Double deletion 290–335, GC, AG
(43 bp, 395 bp), plus 354–748
inversion insertion
W6 184 Deletion (444 bp) 287–731 CGGCDISCUSSION
In this study, we have determined whether the cisplatin-induced
collateral radioresistance that preferentially occurs in inherently
radiosensitive human tumour cells was associated with a reduction
or suppression of non-conservative DSB rejoining activity. Our
data suggest that there is significantly (P < 0.01) lower DSB mis-
rejoining activity within nuclear protein extracts from collaterally
radioresistant (cisplatin-resistant) cell lines than in nuclear protein
extracts from their respective cisplatin- and radiation-sensitive
parental cell lines. This reduction in DSB misrejoining activity
appears to be independent of the DSB rejoining capacity of the cell
lines studied, and it is unlikely to be a manifestation of variations in
cell cycle progression because these measurements were performed
using a cell-free reactivation assay. Clearly, the relative distribution
of the cells within the various cell cycle phases may have a major
impact upon the composition of the nuclear protein extract, but
there are no major differences in the cell cycle distributions of the
cisplatin-sensitive and -resistant cell lines.
Acquired cisplatin resistance is frequently multifactorial, and it
is likely that repeated exposure to cisplatin will induce a spectrum
of genetic mutations that could conceivably alter the fidelity of
DSB rejoining. For example, the induction of cisplatin resistance
in both the 2780/CP and OAW42/CP cell lines was associated with
a decrease in the functionality of the p53 protein (data not shown).
Although circumstantially these data suggest that p53 function-
ality might be an important determinant of DSB misrejoining
activity, recent studies have shown that the introduction of a
mutant p53 gene per se has no impact on DSB misrejoining
activity (Bill et al, 1997). Another phenotypic difference that is
consistently induced after the development of cisplatin resistance
in both the 2780/CP and OAW42/CP cell lines is the reduction in
MLH1 protein levels (data not shown). Differences in mismatch
repair activity could potentially influence DSB misrejoining
activity, because the mismatch repair pathway can repair DSBs
provided there are mismatch repair tracts on both sides of the
break (Weng and Nickoloff, 1997). However, our characterization
of the nuclear protein extract-induced mutations within the lacZa
gene would suggest that the development of cisplatin resistance
had altered processes other than mismatch repair capacity.
Sequencing of the mutant ‘white’ plasmids generated in our
experiments suggests that the inactivation of the lacZa gene was
attributable to deletions of between 136 and 444 bp, all of which
involved combination at distant short sequence repeats (micro-
homologies). There is presently little information on the protein(s)
responsible for the non-conservative DSB rejoining activity that
our assay has detected. To date, only one protein complex has been
purified from mammalian cells that is involved in non-homolo-
gous rejoining (Fishel et al, 1991). This protein complex is not
fully characterized, but it is presently known to consist of the
HPP-1, RPA (also known as human single-stranded DNA-binding
protein-HSSB) and a unique ligase (but not I, II or III). It is
possible that the plasmid reactivation assay has detected differ-
ences in the activity of this protein complex in the cisplatin-
sensitive and -resistant cell lines.
The high level of illegitimate recombination effected by
2780/WT nuclear protein extracts raises the possibility that the
sensitivity of the 2780/WT cells to cisplatin and radiation may be
partly due to an abnormally high level of non-conservative
rejoining activity. A proportion of cisplatin–DNA adducts do
appear to be repaired through a non-homologous recombinational
pathway (Cizeau et al, 1996). Some form of DNA recombination
is certainly required to repair cisplatin interstrand cross-links, and
it seems likely that non-conservative recombination would have a
greater likelihood of leading to cell death (due to loss of critical
DNA) than if the adducts were repaired via a homologous recom-
bination activity. It is, therefore, conceivable that the development
of cisplatin resistance arises through either the selection of cells
that have a preferentially higher level of homologous than non-
homologous recombination (NHR) activity, or the suppression of
the NHR pathway. However, it would appear that the lower DSB
misrejoining frequencies in the 2780/CP and OAW42/CP cell lines
arose because of a genetic or epigenetic alteration induced during
the development of cisplatin resistance because their respective
parental cell lines were clonal in origin. Other than the data
presented here, we are unaware of any data that directly suggests
that radio- or cisplatin-sensitive human tumour cells have a higher
level of NHR activity than their resistant counterparts.
In summary, the 2780 paired cell lines are another example of
human tumour cell lines that differ greatly in radiosensitivity, yet
show equal or similar levels of DSB rejoining (Schwartz and
Vaughan, 1989; Smeets et al, 1993; McKay et al, 1995). These
data in isolation would circumstantially support the notion that
human tumour cell lines may differ in their tolerance to residual
DNA damage, however, the DSB misrejoining data presented in
this paper (Figure 3) and elsewhere (Schwartz and Vaughan, 1989;
Powell and McMillan, 1991; Powell et al, 1992) suggest that the
lethality of radiation-induced DSB may be determined by both the
level and fidelity of DSB rejoining. These data support the notion
that the radiosensitivity of DSB repair-proficient human tumour
cell lines may be partly determined by the predisposition of these
cell lines to activate non-conservative DSB rejoining pathways.
Furthermore, our data suggest that the induction of acquired
cisplatin resistance is associated with a two- to threefold decrease
in the activity of a non-conservative DSB rejoining mechanism
that appears to be a manifestation of NHR. These data provide a
novel insight into the potential role that NHR activity might play
as a predisposing factor to both radiation and cisplatin sensitivity
in human tumour cells.
ACKNOWLEDGEMENTS
This work was funded by grants to Dr Richard Britten from the
Alberta Cancer Board-Research Initiative Program (RI-116). We
are grateful to Dr David Murray for his advice and guidance with
the Alu-based Southern Analysis of PFGE gels, and to Dr Joan
Allalunis-Turner for the provision of the DNA-PKcs antibody.
REFERENCES
Bill CA, Yu Y, Miselis NR, Little JB and Nickoloff JA (1997) A role for p53 in
DNA end rejoining by human cell extracts. Mutant Res 385: 21–29
Britten RA, Warenius HM, Masters JRW and Peacock JH (1993) The differential
induction of collateral resistance to 62.5 MeV (p®Be+) neutrons and 4 MeV
photons by exposure to cis-platinum. Int J Radiat Oncol Biol Phys 26: 837–843
Britten RA, Warenius HM, Carraway AV and Murray D (1994) Differential
modulation of radiosensitivity following induction of cis-platinum resistance in
radiation-sensitive and radiation-resistant human tumor cells. Radiat Oncol
Invest 2: 25–31
Britten RA, Liu D, Kuny S and Allalunis-Turner MJ (1997) Differential level of
DSB repair fidelity effected by nuclear protein extracts derived from
radiosensitive and radioresistant human tumour cells. Br J Cancer 76:
1440–1447
848 RA Britten et al
British Journal of Cancer (1999) 79(5/6), 843–849 © Cancer Research Campaign 1999Bryant PE and Liu N (1994) Responses of radiosensitive repair-proficient cell lines
to restriction endonucleases. Int J Radiat Biol 66: 597–601
Cizeau J, Decoville M, Leng M and Locker D (1996) Large deletions in the white
gene of Drosophila melanogaster by the antitumoral drug cis-
dichlorodiammineplatinum (II): influence of non-homologous recombination.
Mutat Res 356: 197–202
Cox R, Masson WK, Debenham PG and Webb MBT (1984) The use of recombinant
DNA plasmids for the determination of DNA-repair and recombination in
cultured mammalian cells. Br J Cancer 49 (suppl. VI): 67–72
Fishel R, Derbyshire MK, Moore SP and Young CSH (1991) Biochemical studies of
homologous and nonhomologous recombination in human cells. Biochimie 73:
257–267
Ganesh A, North P and Thacker J (1993) Repair and misrepair of site-specific DNA
double-strand breaks by human cell extracts. Mutat Res 299: 251–259
Giaccia A, Weinstein R, Hu J and Stomato TD (1985) Cell cycle repair of double-
strand DNA breaks in a gamma-ray-sensitive Chinese hamster cell. Somat Cell
Mol Genet 11: 485–491
Hida T, Ueda R, Takahashi T, Watanabe H, Kato T, Suyama M, Sugiura T, Ariyoshi
Y and Takahashi T (1989) Chemosensitivity and radiosensitivity of small cell
lung cancer cell lines studied by a newly developed 3-(4,5-dimethylthiazol-2-
yl)-2,5-diphenyltetrazolium bromide (MTT) hybrid assay. Cancer Res 49:
4785–4790
Kirchgessner CU, Patil CK, Evans JW, Cuomo CA, Fried LM, Carter T, Oettinger
MA and Brown JM (1995) DNA-dependent kinase (p350) as a candidate gene
for the murine SCID defect. Science 267: 1178–1183
Lambin P, Coco-Martin J, Legal JD, Begg AC, Parmentier C, Joiner MC and
Malaise EP (1994) Intrinsic radiosensitivity and chromosome aberration
analysis using fluorescence in situ hybridization in cells of two human tumor
cell lines. Radiat Res 138: S40–43
Lees-Miller SP, Godbout R, Chan DW, Weinfeld M, Day RS, Barron GM and
Allalunis-Turner J (1995) Absence of p350 subunit of DNA-activated protein
kinase from a radiosensitive human cell line. Science 267: 1183–1185
Liu N and Bryant PE (1993) Response of ataxia telangiectasia cells to restriction
endonuclease induced DNA double-strand breaks. I. Cytogenetic
characterization. Mutagenesis 8: 503–510
Lou C-M, Tang W, Mekeel KL, DeFrank JS, Rani Anné P and Powell SN (1996)
High frequency and error-prone DNA recombination in ataxia telangiectasia
cell lines. J Biol Chem 271: 4497–4503
Louie KG, Behrens BC, Kinsella TJ, Hamilton TC, Grotzinger KR, McKoy WM,
Winker MA and Ozols RF (1985) Radiation survival parameters of
antineoplastic drug-sensitive and -resistant human ovarian cell lines and their
modification by buthionine sulfoximine. Cancer Res 45: 2110–2115
McKay MJ and Kefford RF (1995) The spectrum of in vitro radiosensitivity in four
human melanoma cell lines is not accounted for by differential induction or
rejoining of DNA double strand breaks. Int J Radiat Oncol Biol Phys 31:
345–352
Murray D, Simpson R, Rosenberg E, Carraway A and Britten R (1994) Correlation
between g-ray induced DNA double-strand breakage and cell killing after
biologically relevant doses: analysis by pulsed-field gel electrophoresis. Int J
Radiat Biol 65: 419–426
Olive PL, Banáth JP and MacPhail HS (1994) Lack of a correlation between
radiosensitivity and DNA double-strand break induction or rejoining in six
human tumor cell lines. Cancer Res 54: 3939–3946
Powell S and McMillan TJ (1991) Clonal variation of DNA repair in a human
glioma cell line. Radiother Oncol 21: 225–232
Powell SN and McMillan TJ (1994) The repair fidelity of restriction enzyme-
induced double strand breaks in plasmid DNA correlates with radioresistance
in human tumor cell lines. Int J Radiat Oncol Biol Phys 29: 1035–1040
Powell SN, Whitaker SJ, Edwards SM and McMillan TJ (1992) A DNA repair
defect in a radiation-sensitive clone of a human bladder carcinoma cell line.
Br J Cancer 65: 798–802
Powell SN, Whitaker S, Peacock JH and McMillan TJ (1993) Ataxia telangiectasia:
an investigation of the repair defect in the cell line AT5BIVA by plasmid
reconstitution. Mutat Res 294: 9–20
Russell NS, Arlett CF, Bartelink H and Begg AC (1995) Use of fluorescence in situ
hybridization to determine the relationship between chromosome aberrations
and cell survival in eight human fibroblast strains. Int J Radiat Biol 68:
185–196
Sasai K, Evans JW, Kovacs MS and Brown JM (1994) Prediction of human cell
radiosensitivity: comparison of clonogenic assay with chromosome aberrations
scored with premature chromosome condensation with fluorescence in situ
hybridization. Int J Radiat Oncol Biol Phys 30: 1127–1132
Schwartz JL and Vaughan ATM (1989) Association among DNA/chromosome break
rejoining rates, chromatin structure alterations, and radiation sensitivity in
human tumor cell lines. Cancer Res 49: 5054–5057
Smeets MFMA, Mooren EHM and Begg AC (1993) Radiation-induced DNA
damage and repair in radiosensitive and radioresistant human tumour cells
measured by field inversion gel electrophoresis. Int J Radiat Biol 63: 703–713
Taccioli GE, Gottlieb TM, Blunt T, Priestley A, Demengeot J, Mizuta R, Lehmann
AR, Alt FW, Jackson SP and Jeggo PA (1994) Ku80: product of XRCC5 gene
and its role in DNA repair and V(D)J recombination. Science 265: 1442–1445
Thacker J and Ganesh AN (1990) DNA-break repair, radioresistance of DNA
synthesis, and camptothecin sensitivity in the radiation-sensitive irs mutants:
comparisons to ataxia-telangiectasia cells. Mutat Res 235: 49–58
Thacker J, Chalk J, Ganesh A and North P (1992) A mechanism for deletion
formation in DNA by human cell extracts: the involvement of short sequence
repeats. Nucleic Acids Res 20: 6183–6188
Turchi JJ, Patrick SM and Henkels KM (1997) Mechanisms of DNA-dependent
protein kinase inhibition by cis-diamminedichloroplatinum(II)-damaged DNA.
Biochemistry 36: 7586–7593
Twentyman PR, Wright KA and Rhodes T (1991) Radiation response of human lung
cancer cells with inherent and acquired resistance to cisplatin. Int J Radiat
Oncol Biol Phys 20: 217–220
Weng G and Nickoloff J (1997) Conversion on opposite sides of a double-strand
break can be mediated by two mismatch repair tracts. Proc Am Assoc Cancer
Res 38: A2399
The effect of cisplatin resistance on DSB misrepair 849
British Journal of Cancer (1999) 79(5/6), 843–849 © Cancer Research Campaign 1999